Lv1
74 积分 2025-03-17 加入
Montmorillonite restricts free fatty acid liberation and alters self-assembled structures formed during in vitro lipid digestion
5天前
已完结
Clinical practice guidelines for acute infectious diarrhea in children in China (2024)
5天前
已完结
Myosin light chain kinase-mediated epithelial barrier dysfunction as a potential pathogenic mechanism of afatinib-induced diarrheas: A study in human colonoid model
5天前
已完结
Guselkumab-mediated marked improvement in a case of refractory ulcerative colitis resistant to mirikizumab: evidence for switching between IL-23p19 inhibitors
19天前
已完结
Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study
19天前
已完结
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
1个月前
已完结
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
1个月前
已关闭
Su1841: EFFICACY AND SAFETY OF UPADACITINIB AFTER 4 YEARS OF TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: INTERIM LONG-TERM DATA FROM THE PHASE 3 OPEN-LABEL EXTENSION STUDY (U-ACTIVATE)
1个月前
已关闭
Prospective real-world experience with risankizumab in difficult-to-treat Crohn’s disease: results from the Dutch Initiative on Crohn and Colitis Registry
1个月前
已关闭
Evaluating Choice of Biologics for Isolated Small-Bowel Crohn’s Disease
1个月前
已关闭
皖公网安备34019202002308
